Get the latest updates and insights delivered to your inbox
Aug 19, 2026
Moderna and Merck make progress in melanoma vaccine testing
A major breakthrough in cancer treatment as Moderna and Merck say an mRNA vaccine showed promise in a trial dealing with melanoma.
For more, KCBS's Margie Shafer spoke with Dr. Adil Daud, UCSF oncologist and co-director of the Melanoma Center.
Getty Images // Jacob Wackerhausen